Mexico Ministry of Health updates rules and requirements for medical device classification
23 May 2023
Ana Karen Hidalgo Rodríguez, Emergo Group
Continuing with our updates over the recently released 5.0 edition of the Supplement of Medical Devices of the Mexican Pharmacopoeia (hereafter: Pharmacopoeia), we discuss the classification rules related to medical devices.
Classification of medical devices based on their level of risk
Appendix II of the Mexican Pharmacopoeia includes the criteria under which medical devices are classified in Mexico based on their risk level.
The established criteria have always been presented as rules, indicating the characteristics of medical devices in relation to their use, activity, contact and permanence with the body. The rules-based system is based on the former Global Harmonization Task Force (GHTF), now the International Medical Device Regulators Forum or IMDRF, and EU Medical Devices Directive MDD 93/42/EEC. In addition, the revised rules appear to consider the EU Medical Devices Regulation 2017/745 (MDR). Understanding and following these rules will help with obtaining a registration for medical devices in Mexico.
There are an additional 12 rules added to the 23 previous rules, 10 of which are related to IVDs, and which will be discussed in another Regulatory Update.
There are now seven classification categories. In this newly published version of the Pharmacopoeia, medical device categories have increased from six to seven, with the seventh exclusive for software as a medical device (SaMD) and its corresponding definition (discussed in our previous update):
Medical Equipment
Prosthesis
Orthesis and functional aids, IVDs
Dental Supplies
Surgical and healing materials
Hygiene products
SaMD
The categories may seem immaterial to manufacturers, but are used by COFEPRIS regulators in their organization and review.
Get the full story — including rules for invasive and noninvasive medical devices — at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MedicalDesignandOutsourcing.com or its employees.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.